{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:04:00Z","timestamp":1790186640344,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gen Thorac Cardiovasc Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Postoperative atrial fibrillation (POAF) remains a common complication after off-pump coronary artery bypass grafting (OPCAB). We evaluated the preventive effect of short-term perioperative landiolol hydrochloride administration on POAF after OPCAB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center retrospective observational study included patients who underwent elective isolated OPCAB between February 2013 and August 2018. Patients with a history of atrial fibrillation, emergency surgery, or conversion to cardiopulmonary bypass were excluded. Landiolol hydrochloride was continuously administered from the beginning of surgery until postoperative day 1. The primary endpoint was POAF occurrence. Secondary endpoints included hospital stay, perioperative complications, and healthcare insurance reimbursement points. Propensity score matching was performed to adjust baseline differences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among eligible patients, 74 were assigned to the control group and 159 to the landiolol group. Propensity score matching generated 68 matched pairs. POAF incidence was significantly lower in the landiolol group in both the unadjusted cohort (15.7% vs. 31.1%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.01) and propensity score matched cohort (14.7% vs. 32.4%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02). No significant differences were observed in hospital stay or major clinical outcomes, including 30-day mortality, stroke, and prolonged intubation. However, medical insurance points were significantly lower in the matched intervention group (258,460 vs. 267,904 points,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.047).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Short-term perioperative administration of landiolol hydrochloride was associated with a lower incidence of POAF after OPCAB without an increase in perioperative complications. While further prospective randomized studies are needed, this simplified protocol may offer a safe, feasible, and potentially cost-favorable strategy for POAF prevention after cardiac surgery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11748-026-02355-y","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:51:28Z","timestamp":1783345888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intraoperative landiolol hydrochloride use for prevention of postoperative atrial fibrillation with off-pump coronary artery bypass graft surgery (ILUPAF-OPCAB) study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7156-9398","authenticated-orcid":false,"given":"Satoshi","family":"Teranishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asako","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh","family":"Kajiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisato","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Kanemitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Fujinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Shomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Mizumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"2355_CR1","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/eurheartj\/ehad019","volume":"44","author":"M Gaudino","year":"2023","unstructured":"Gaudino M, Franco AD, Rong QL, Piccini J, Mack M. Postoperative atrial fibrillation: from mechanisms to treatment. Eur Heart J. 2023;44:1020\u201339.","journal-title":"Eur Heart J"},{"key":"2355_CR2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.athoracsur.2020.05.104","volume":"111","author":"R Eikelboom","year":"2021","unstructured":"Eikelboom R, Sanjanwala R, Le ML, Yamashita MH, Arora RC. Postoperative atrial fibrillation after cardiac surgery: a systematic review and meta-analysis. Ann Thorac Surg. 2021;111:544\u201354.","journal-title":"Ann Thorac Surg"},{"key":"2355_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/europace\/eur208","volume":"14","author":"B Maesen","year":"2012","unstructured":"Maesen B, Nijs J, Maessen J, Allessie M, Schotten U. Post-operative atrial fibrillation: a maze of mechanisms. Europace. 2012;14:159\u201374.","journal-title":"Europace"},{"key":"2355_CR4","unstructured":"Japanese Association for Coronary Artery Surgery. Coronary artery surgery results 2018. Accessed September 15, 2025. http:\/\/jacas.org"},{"key":"2355_CR5","first-page":"100621","volume":"59","author":"AK Awad","year":"2025","unstructured":"Awad AK, Elbahloul MA, Al-Omoush O, Abdelnasser O, Hajali M, Abdelnasser A, et al. Impact of postoperative atrial fibrillation (POAF) on outcomes after coronary artery bypass grafting: A meta-analysis of unique 247,270 patients from 50 studies. Am Heart J Plus. 2025;59:100621.","journal-title":"Am Heart J Plus"},{"key":"2355_CR6","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.jacc.2005.05.064","volume":"46","author":"DN Wijeysundera","year":"2005","unstructured":"Wijeysundera DN, Beattie WS, Djaiani G, Rao V, Borger MA, Karkouti K, et al. Off-pump coronary artery surgery for reducing mortality and morbidity: meta-analysis of randomized and observational studies. J Am Coll Cardiol. 2005;46:872\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"2355_CR7","doi-asserted-by":"publisher","first-page":"928732925133038","DOI":"10.1177\/09287329251330386","volume":"30","author":"E Jahic","year":"2025","unstructured":"Jahic E, Osmanovic E, Djedovic S, Cerovac A, Avdic S, Avdic-Salihovic A, et al. Postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting with and without use of cardiopulmonary bypass. Technol Health Care. 2025;30:9287329251330386.","journal-title":"Technol Health Care"},{"key":"2355_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jtcvs.2011.10.003","volume":"143","author":"GH Almassi","year":"2012","unstructured":"Almassi GH, Pecsi SA, Collins JF, Shroyer AL, Zenati MA, Grover FL. Predictors and impact of postoperative atrial fibrillation on patients\u2019 outcomes: a report from the Randomized On Versus Off Bypass trial. J Thorac Cardiovasc Surg. 2012;143:93\u2013102.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2355_CR9","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1093\/eurheartj\/ehl272","volume":"27","author":"DC Burgess","year":"2006","unstructured":"Burgess DC, Kilborn MJ, Keech AC. Interventions for prevention of postoperative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur Heart J. 2006;27:2846\u201357.","journal-title":"Eur Heart J"},{"key":"2355_CR10","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.jtcvs.2010.10.045","volume":"141","author":"A Sezai","year":"2011","unstructured":"Sezai A, Minami K, Nakai T, Hata M, Yoshitake I, Wakui S, et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: a randomized controlled trial. J Thorac Cardiovasc Surg. 2011;141:1478\u201385.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2355_CR11","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.jtcvs.2012.06.042","volume":"144","author":"A Sezai","year":"2012","unstructured":"Sezai A, Nakai T, Hata M, Yoshitake I, Shiono M, Kunimoto S, et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. J Thorac Cardiovasc Surg. 2012;144:1241\u20138.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2355_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.5761\/atcs.oa.12.02003","volume":"20","author":"E Nagaoka","year":"2014","unstructured":"Nagaoka E, Arai H, Tamura K, Makita S, Miyagi N. Prevention of atrial fibrillation with ultra-low dose landiolol after off-pump coronary artery bypass grafting. Ann Thorac Cardiovasc Surg. 2014;20:129\u201335.","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"2355_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/0218492312451166","volume":"21","author":"S Ogawa","year":"2013","unstructured":"Ogawa S, Okawa Y, Goto Y, Aoki M, Baba H. Perioperative use of a beta blocker in coronary artery bypass grafting. Asian Cardiovasc Thorac Ann. 2013;21:265\u201370.","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"2355_CR14","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/BF03016588","volume":"48","author":"J Sasao","year":"2001","unstructured":"Sasao J, Tarver SD, Kindscher JD, Taneyama C, Benson KT, Goto H. In rabbits, landiolol, a new ultra-short-acting \u03b2-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol. Can J Anaesth. 2001;48:985\u201391.","journal-title":"Can J Anaesth"},{"key":"2355_CR15","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/ejcts\/ezx039","volume":"52","author":"JW Greenberg","year":"2017","unstructured":"Greenberg JW, Lancaster TS, Schuessler RB, Melby SJ. Postoperative atrial fibrillation following cardiac surgery: a persistent complication. Eur J Cardiothorac Surg. 2017;52:665\u201371.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2355_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.pharmthera.2015.06.009","volume":"154","author":"M Zakker","year":"2015","unstructured":"Zakker M, Ascione R, James AF, Angelini GD, Suleiman MS. Inflammation, oxidative stress and postoperative atrial fibrillation in cardiac surgery. Pharmacol Ther. 2015;154:13\u201320.","journal-title":"Pharmacol Ther"},{"key":"2355_CR17","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1161\/01.CIR.102.13.1530","volume":"102","author":"R Ascione","year":"2000","unstructured":"Ascione R, Caputo M, Calori G, Lloyd MJ, Angelini GD. Predictors of atrial fibrillation after conventional and beating heart coronary surgery. Circulation. 2000;102:1530\u20135.","journal-title":"Circulation"},{"key":"2355_CR18","first-page":"369","volume":"53","author":"M Fujii","year":"2012","unstructured":"Fujii M, Bessho R, Shimizu K, Terajima K, Takeda S. Effect of postoperative landiolol administration for atrial fibrillation after off pump coronary artery bypass surgery. J Cardiovasc Surg. 2012;53:369\u201374.","journal-title":"J Cardiovasc Surg"},{"key":"2355_CR19","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1053\/j.jvca.2022.02.016","volume":"36","author":"A Ferraris","year":"2022","unstructured":"Ferraris A, Jacquet-Lagreze M, Cazenave L, Fornier W, Jalalzai W, Rousseau-Saine N, et al. Effects of landiolol on macrocirculatory parameters and left and right ventricular performances following cardiac surgery: a randomized controlled trial. J Cardiothorac Vasc Anesth. 2022;36:2864\u20132864.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2355_CR20","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1007\/s12630-023-02586-0","volume":"70","author":"T Cafaro","year":"2023","unstructured":"Cafaro T, Allwood M, Mclntyre WF, Park LJ, Daza J, Ofori SN, et al. Landiolol for the prevention of postoperative atrial fibrillation after cardiac surgery: a systematic review and meta-analysis. Can J Anesth. 2023;70:1828\u201338.","journal-title":"Can J Anesth"},{"key":"2355_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5761\/atcs.ra.21-00126","volume":"28","author":"J Hao","year":"2022","unstructured":"Hao J, Zhou J, Xu W, Chen C, Zhang J, Peng H, et al. Beta-blocker landiolol hydrochloride in preventing atrial fibrillation following cardiothoracic surgery: a systematic review and meta-analysis. Ann Thorac Cardiovasc Surg. 2022;28:18\u201331.","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"2355_CR22","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1053\/j.jvca.2019.11.003","volume":"34","author":"E Walter","year":"2020","unstructured":"Walter E, Heringlake M. Cost-effectiveness analysis of landiolol, an ultrashort-acting beta-blocker, for prevention of postoperative atrial fibrillation for the Germany health care system. J Cardiothorac Vasc Anesth. 2020;34:888\u201395.","journal-title":"J Cardiothorac Vasc Anesth"}],"container-title":["General Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11748-026-02355-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11748-026-02355-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11748-026-02355-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:12:57Z","timestamp":1790143977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11748-026-02355-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":22,"alternative-id":["2355"],"URL":"https:\/\/doi.org\/10.1007\/s11748-026-02355-y","relation":{},"ISSN":["1863-6705","1863-6713"],"issn-type":[{"value":"1863-6705","type":"print"},{"value":"1863-6713","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}